Expertise in
1
conditions

Dr. Yun-sen Chu

Ophthalmology
Chu Surgery Center
9117 Lyndale Ave S, 
Bloomington, MN 
Expertise in
1
conditions
Chu Surgery Center
9117 Lyndale Ave S, 
Bloomington, MN 

Overview

Yun-sen Chu is an Ophthalmologist in Bloomington, Minnesota. Dr. Chu is highly rated in 1 condition, according to our data. His top areas of expertise are Cataract, Presbyopia, Glaucoma, and Dry Eye Syndrome.

His clinical research consists of participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Ophthalmology

Licenses

Ophthalmology in MN

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

Chu Surgery Center
9117 Lyndale Ave S, Bloomington, MN 55420

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Multicenter, Randomized, Double-Masked, Dose-Ranging Study To Compare The Ocular Safety, Tolerability, And Efficacy Of SURF-200 Ophthalmic Solution (0.02% And 0.04% Betamethasone Sodium Phosphate) To Vehicle In Subjects With A Diagnosis Of Dry Eye Disease And Experiencing An Episodic Flare Up
A Multicenter, Randomized, Double-Masked, Dose-Ranging Study To Compare The Ocular Safety, Tolerability, And Efficacy Of SURF-200 Ophthalmic Solution (0.02% And 0.04% Betamethasone Sodium Phosphate) To Vehicle In Subjects With A Diagnosis Of Dry Eye Disease And Experiencing An Episodic Flare Up
Enrollment Status: Completed
Publish Date: June 04, 2025
Intervention Type: Drug
Study Drug: Betamethasone Sodium Phosphate
Study Phase: Phase 2
A Phase III, Multi-center Study to Evaluate the Safety and Efficacy of Epithelium-on Corneal Collagen Cross-linking in Eyes With Progressive Keratoconus
A Phase III, Multi-center Study to Evaluate the Safety and Efficacy of Epithelium-on Corneal Collagen Cross-linking in Eyes With Progressive Keratoconus
Enrollment Status: Completed
Publish Date: January 30, 2024
Intervention Type: Drug, Device
Study Phase: Phase 3
A Clinical Trial to Evaluate the Safety and Effectiveness of Model SC9 Silicone IOL for the Visual Correction of Aphakia Secondary to the Removal of a Cataractous Lens in Adult Patients With or Without Presbyopia
A Clinical Trial to Evaluate the Safety and Effectiveness of Model SC9 Silicone IOL for the Visual Correction of Aphakia Secondary to the Removal of a Cataractous Lens in Adult Patients With or Without Presbyopia
Enrollment Status: Terminated
Publish Date: August 30, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Prospective Study To Evaluate The Raindrop Near Vision Inlay In Presybopic or Pseudophakic Patients Treated With Mitomycin C Following Femtosecond Flap Creation.
A Prospective Study To Evaluate The Raindrop Near Vision Inlay In Presybopic or Pseudophakic Patients Treated With Mitomycin C Following Femtosecond Flap Creation.
Enrollment Status: Terminated
Publish Date: August 18, 2022
Intervention Type: Drug, Device
Study Phase: Phase 4
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Expertise in
27
conditions
Dr. Geoffrey Emerson
Ophthalmology
Expertise in
27
conditions
Dr. Geoffrey Emerson
Ophthalmology

Retina Center PA

710 E 24th St Ste 304, 
Minneapolis, MN 
 (8.6 miles away)
612-871-2292
Languages Spoken:
English
See accepted insurances

Geoffrey Emerson is an Ophthalmologist in Minneapolis, Minnesota. Dr. Emerson is highly rated in 27 conditions, according to our data. His top areas of expertise are Retinal Detachment, Endophthalmitis, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Vitrectomy.

Expertise in
25
conditions
Dr. Michael Lee
Ophthalmology
Expertise in
25
conditions
Dr. Michael Lee
Ophthalmology

University Of Minnesota Masonic Children's Hospital

420 Delaware St SE, 
Minneapolis, MN 
 (9.7 miles away)
612-625-4400
Languages Spoken:
English
See accepted insurances

Michael Lee is an Ophthalmologist in Minneapolis, Minnesota. Dr. Lee is highly rated in 25 conditions, according to our data. His top areas of expertise are Papilledema, Increased Intracranial Pressure, Optic Nerve Atrophy, Atherectomy, and Angioplasty.

Expertise in
6
conditions
Dr. Thomas Samuelson
Ophthalmology
Expertise in
6
conditions
Dr. Thomas Samuelson
Ophthalmology

Bloomington Office

9801 DuPont Ave S Ste 200, 
Minneapolis, MN 
 (1.9 miles away)
952-888-5800
Languages Spoken:
English
See accepted insurances

Thomas Samuelson is an Ophthalmologist in Minneapolis, Minnesota. Dr. Samuelson is highly rated in 6 conditions, according to our data. His top areas of expertise are Pigment-Dispersion Syndrome, Glaucoma, Ocular Hypertension (OHT), Trabeculectomy, and Cataract Removal.

Frequently Asked Questions about Dr. Yun-sen Chu

How do I make an appointment with Dr. Yun-sen Chu?

You can book an appointment with Dr. Yun-sen Chu by calling their office at 952-208-4735. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Yun-sen Chu a top-rated expert for Cataract?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Yun-sen Chu is classified as an Distinguished expert for Cataract, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Yun-sen Chu specialize in?

While Dr. Yun-sen Chu is a Ophthalmology, they have specific expertise in Cataract, Presbyopia, and Glaucoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.

Does Dr. Yun-sen Chu accept my insurance?

Dr. Yun-sen Chu accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 952-208-4735 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chu's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile